To further validate that the ephrinB2 downregulation following ZEB2 induction functionally regulates evasive resistance to bevacizumab treatment we generated G55 tumour cells with constitutively elevated ephrinB2 levels (Fig. 7d). Here, EFNB2 is linked to neoplasm.